These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 993319)

  • 21. Identification of a specific inhibitor of nonsuppressible insulin-like activity in a partially purified human serum fraction.
    Herington AC; Kuffer AD
    Endocrinology; 1981 Nov; 109(5):1634-40. PubMed ID: 7297496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An assay for plasma somatomedin: [3H]thymidine incorporation by isolated rabbit chondrocytes.
    Ashton IK; Francis MJ
    J Endocrinol; 1977 Aug; 74(2):205-12. PubMed ID: 894168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current concepts of somatomedin and other biologically related growth factors.
    Chochinov RH; Daughaday WH
    Diabetes; 1976 Oct; 25(10):994-1004. PubMed ID: 185112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonsuppressible insulinlike activity (NSILA) and the glucose dyshomeostasis of agonal sepsis.
    Viray RE; Filkins JP
    Adv Shock Res; 1983; 9():31-41. PubMed ID: 6349307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.
    Cornell HJ; Bistrin M; Herington AC
    Int J Biochem; 1985; 17(9):1003-8. PubMed ID: 4065403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-suppressible insulin-like serum activity (NSILA). Physiological importance and survey of the current state of research].
    Zapf J
    Fortschr Med; 1980 Jan; 98(2):66-8. PubMed ID: 7364359
    [No Abstract]   [Full Text] [Related]  

  • 27. [Competitive protein-binding assay for somatomedins and their carrier protein (author's transl)].
    Binoux M; Lassarre C; Seurin D
    Ann Endocrinol (Paris); 1980; 41(1):67-9. PubMed ID: 7396401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The occurrence of a distinct high molecular weight form of serum non-suppressible insulin-like activity.
    Franklin RC; Cameron DP; Burger HG; Herington AC
    Mol Cell Endocrinol; 1979 Nov; 16(2):81-9. PubMed ID: 41788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor.
    Megyesi K; Kahn CR; Roth J; Neville DM; Nissley SP; Humbel RE; Froesch ER
    J Biol Chem; 1975 Dec; 250(23):8990-6. PubMed ID: 391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum levels of receptor assayable insulin-like activity in various diseases].
    Namba O; Hyodo T
    Nihon Naibunpi Gakkai Zasshi; 1983 Nov; 59(11):1714-28. PubMed ID: 6365608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a receptor for somatomedin-like polypeptides in human fibroblasts.
    Rechler MM; Nissley SP; Podskalny JM; Moses AC; Fryklund L
    J Clin Endocrinol Metab; 1977 May; 44(5):820-31. PubMed ID: 192752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency of non-suppressible insulin-like activity in thalassaemia major.
    Werther GA; Matthews R; Burger HG; Herington AC
    Arch Dis Child; 1981 Nov; 56(11):855-9. PubMed ID: 7305429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [NSILA, insulin-like growth factors and somatomedins (author's transl)].
    Froesch ER
    Schweiz Rundsch Med Prax; 1979 Mar; 68(13):412-6. PubMed ID: 432207
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence for a biologically active, carrier-bound form of non-suppressible insulin-like activity (NSILA) in human serum.
    Cornell HJ; Herington AC
    Int J Biochem; 1983; 15(4):553-8. PubMed ID: 6852354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From insulin and insulin-like activity to the insulin superfamily of growth-promoting peptides: a 20th-century odyssey.
    Blumenthal S
    Perspect Biol Med; 2010; 53(4):491-508. PubMed ID: 21037404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of hypophysectomy on NSILA concentrations in the dog: evidence for partially pituitary-independent regulation.
    Eigenmann JE; Becker M; Kammermann B; Zapf J; Leemann W; Froesch ER
    Acta Endocrinol (Copenh); 1977 Nov; 86(3):498-503. PubMed ID: 579020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain growth-promoting activity in human serum: relationship to growth hormone and somatomedin.
    Sara VR; Stuart MC; Rutherford R; Moore S; Lazarus L
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1129-31. PubMed ID: 263343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-suppressible insulin-like activity during acute metabolic and endocrine changes in dogs.
    Eigenmann JE; Francke-Mäder M; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):571-8. PubMed ID: 577341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The purification and partial characterization of an insulin-like protein from human serum.
    Poffenbarger PL
    J Clin Invest; 1975 Dec; 56(6):1455-63. PubMed ID: 1202080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of serum nonsuppressible insulin-like activity (NSILA) in compensatory renal growth.
    Poffenbarger PL; Prince MJ
    Growth; 1976 Mar; 40(1):83-97. PubMed ID: 177337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.